Retinoblastoma: Expression of HLA-G

Ocular Immunology and Inflammation

Volumn 14, Issue 4, 2006, Pages 207-213

  Adithi, Mohan ^a   Kandalam, Mallikarjuna ^a   Ramkumar, Hema L ^b   Subramanian, Ayshwarya ^c   Venkatesan, Nalini ^a   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Biological Sciences   (India)

Author keywords

Differentiation; HLA G; Immune escape; Invasion; Retinoblastoma

Indexed keywords

HLA ANTIGEN; HLA G ANTIGEN; MONOCLONAL ANTIBODY; PARAFFIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER THERAPY; CELL INTERACTION; CHILD; CHILDHOOD CANCER; CHOROID TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFANT; INTRAOCULAR TUMOR; MALE; NATURAL KILLER CELL; OPTIC NERVE TUMOR; RETINOBLASTOMA; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR ESCAPE; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; NEOPLASM INVASIVENESS; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 33747588333     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940600826497     Document Type: Article

References (24)

1. Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathological analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40:265-267.
2. Gallie BL, Dupont B, Whitsett C, Kitchen FD, Ellsworth RM, Good RA. Histocompatibility typing in spontaneous regression of retinoblastoma. Prog Clin Biol Res. 1977;16:229-237.
3. Char DH, Wood IS, Huhta K, Rand N, Morita CT, Howes JR, EL. Retinoblastoma: tissue culture lines and monoclonal antibody studies. Invest Ophthalmol Vis Sci. 1984;25:30-40.
4. Krishnakumar S, Sundaram A, Abhyankar D, et al. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma. Cancer. 2004;100:1059-1069.
5. Chevez-Barrios P, Hurwitz MY, Louie K, et al. Metastatic and nonmetastatic models of retinoblastoma. Am J Pathol. 2000;157:1405-1412.
6. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248:220-223.
7. McMaster MT, Librach CL, Zhou Y, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. 1995;154:3771-3778.
8. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol. 2001;166:5018-5026.
9. Perez-Villar JJ, Melero I, Navarro F, et al. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol. 1997;158:5736-5743.
10. Carosella ED, Dausset J. Progress of HLA-G in cancer. Semin Cancer Biol. 2003;13:315-316.
11. Rouas-Freiss N, Moreau P, Menier C, Carosella ED. HLA-G in cancer: a way to turn off the immune system. Semin Cancer Biol. 2003;13:325-336.
12. Folberg R, Salomao D, Grossniklaus HE, Proia AD, Rao NA, Cameron JD. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Am J Surg Pathol. 2003;27(1):999-1004.
13. Hurks HM, Valter MM, Wilson L, Hilgert I, van den Elsen PJ, Jager MJ. Uveal melanoma: no expression of HLA-G. Invest Ophthalmol Vis Sci. 2001;42:3081-3084.
14. Anastassiou G, Rebmann V, Wagner S, Bornfeld N, Grosse-Wilde H. Expression of classic and nonclassic HLA class I antigens in uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:2016-2019.
15. Robert PY, Lasalmonie C, Cogne M, Adenis JP, Drouet M. HLA-G and classical HLA class I transcripts in various components of the adult human eye. Eur J Immunogenet. 1999;26:271-274.
16. Davies B, Hiby S, Gardner L, Loke YW, King A. HLA-G expression by tumors. Am J Reprod Immunol. 2001;45:103-107.
17. Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol. 2003;24:82-87.
18. Zierhut M, Streilein JW, Schreiber H, Jager MJ, Ruiter D, Ksander BR. Immunology of ocular tumours. Immunol Today. 1999;20:482-485.
19. Niederkorn JY, Wang S. Immunology of intraocular tumors. Ocul Immunol Inflamm. 2005;13:105-110.
20. Mohan A, Kandalam M, Ramkumar H, Gopal L, Krishnakumar S. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. Br J Ophthalmol. 2006;90:889-893.
21. Krishnakumar S, Kandalam M, Mohan A, et al. Expression of Fas ligand in retinoblastoma. Cancer. 2004;101:1672-1676.
22. Shanmugam MP, Lakshmi A, Biswas J, Krishnakumar S. Prognostic significance of Fas expression in retinoblastoma. Ocul Immunol Inflamm. 2003;11:107-113.
23. Mohan A, Mallikarjuna K, Venkatesan N, Abhyankar D, Parekh PM, Krishnakumar S. The study of c-Src kinase and pStat3 protein expression in retinoblastoma. Exp Eye Res. [In press] 2006.
24. Adithi M, Nalini V, Krishnakumar S. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma. Cancer. 2005;103:1701-1711.